Autologous stem cell-based therapy offers many advantages over other nonsurgical treatments of peripheral arterial disease. Transplant stem cells are a renewable source of multiple cytokines and growth factors. Autologous adult stem cells are not rejected and do not form teratomas. Early preliminary results indicate that adult stem cell therapy is safe and effective in patients with critical limb ischemia.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/1531003507313300 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!